SOAT1 and Alzheimer disease: This study examines the potential of CBG as a treatment for AD by investigating its effects on the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, a key regulator of cytokine signaling and immune responses in skin diseases.